Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

R-SeNSAR Feasibility Study: The Role of Sentinel Node Biopsy in Patients With Anal Cancer

NCT02162641 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT02162641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
R-SeNSAR Feasibility Study: The Role of Sentinel Node Biopsy in Patients With Anal Cancer
Lead sponsor
The Christie NHS Foundation Trust
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2014
Completion date
May 31, 2015
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the anus